Papers and Reports
April 7, 2021

Microcurrent Stimulation Is Effective in Treating Lateral Epicondylitis (Tennis Elbow)

Published on: 
April 7, 2021
NuroKor Team
Published on: 
December 21, 2022

Microcurrent Stimulation Is Effective in Treating Lateral Epicondylitis (Tennis Elbow)

Lateral epicondylitis, also known as tennis elbow, is a tendinopathy of the arm muscles, and the pathophysiology of this condition is related to an overuse injury that also results in microtearing of the extensor carpi radialis brevis and sometimes the extensor digitorum communis muscles.

The first stage of this condition involves the development of inflammation that leads to the formation of granulation tissue and adhesions at the site of the tear.

The typical symptoms include tenderness and pain to palpation over the lateral epicondyle (a bone protuberance in the elbow region) and extensor tendon origin, and pain associated with wrist and gripping motions, as well as decreased function and reduced grip strength.

Lateral epicondylitis is one of the most common overuse injuries in tennis, particularly in the recreational player.

In this population the overall incidence of lateral epicondylitis has been reported to range from 35% to 51%. This condition is treated with various approaches, but often with limited results. There is evidence suggesting that lateral epicondylitis symptoms may persist for over 1 year in up to 20% of people.

Nurokor treats tennis elbow naturally
Lateral epicondylitis

Microcurrent Stimulation For Treating Tennis Elbow

Electrical stimulation is a technique with different modalities involving the delivery of exogenous bioelectrical current. The application of such bioelectrical current has been shown to be effective in treating various conditions, such as neck pain, wound healing, fibromyalgia and cancer bone pain.

Microcurrent stimulation (MCS) is one of the electrical stimulation modalities and has been applied to treat lateral epicondylitis.

In a study, patients afflicted by lateral epicondylitis, were divided into two groups, group A and group B, respectively. Prior to the intervention patients of both groups were assessed for pain intensity, level of disability and grip strength. The assessment revealed that there was not significant difference between the two groups.

Subsequently, Group A received standard exercise therapy in combination with MCS, and group B received standard exercise therapy with sham MCS.

The exercise therapy was the same for both groups, but group A received MCS treatment, which consisted of 30 minutes sessions, whereas group B received sham MCS (the MCS device was set to 0, so that no microcurrent was delivered).

All patients received two sessions per week for a six weeks period.

The results showed that after the intervention, in group A pain and disability decreased significantly, while grip strength increased significantly. Furthermore, the results demonstrated that in group B such improvements were significantly smaller compared with group A.

These findings clearly demonstrate that MCS represents a viable and an effective tool in treating lateral epicondylitis.

In effect, the improvements in pain, disability and grip strength, caused by lateral epicondylitis, were significantly greater in the group of patients who received exercise therapy in conjunction with MCS, compared with the groups of patients who received exercise therapy and sham MCS. The presence of the sham MCS group strengthens the significance of the results, by eliminating any possible placebo effect, and therefore the improvements observed can only be attributed to MCS application.  

In the light of these results, it would be highly desirable to incorporate NuroKor KorOS5 MCS application (MC2) within the standard care routine for lateral epicondylitis treatment.

In the light of these results, it would be highly desirable to incorporate NuroKor KorOS5 MCS application (MC2) within the standard care routine for lateral epicondylitis treatment. As this would be beneficial to patients afflicted by this condition, and is especially relevant to tennis players of all levels, as often they are afflicted by lateral epicondylitis. MCS has many advantages, as it is safe, non-invasive, non-pharmacological, almost side effects free, and can be easily self-administered using any of our devices with correct treatment protocol.       

MCS Protocol  (Study Tarek) Equivalent Application

Frequency of KorOS5 MC2 app; Intensity preset @ 50 microamperes (µA); for 30 minutes each session, 2 sessions per week, for a six weeks period.

Electrode Placement

The lateral epicondyle was identified by palpating the lateral elbow region, and a short line was drawn from it (as a guide), extending distally to indicate the position of the common extensor tendon (this tendon attaches to the lateral epicondyle). The electrodes to be used self-adherent, size 5x5cm. One electrode was placed over the common extensor tendon and the other was placed proximal to the olecranon (a bony prominence at the elbow, on the proximal end of the ulna).

Co author Rick Rowan

About NuroKor:

Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software for clinical and therapeutic applications, in a range of easy to use, wearable devices. It provides the highest-quality products, delivering personalised pain relief and recovery support and rehabilitation to patients.


Barry N, McGuire J. Overuse syndrome in adult athletes. Rheum Dis Clin North Am 1996; 22:515–30.

Carley and Wainapel. Electrotherapy for acceleration of wound healing: low intensity direct current. Archives of Physical Medicine and Rehabilitation. 1985. vol. 66.

Carroll R. Tennis elbow: incidence in local league players. Br J Sports Med 1981;15:250–6.

Dailey DL, Rakel BA, Vance CG et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain. 2013. 154, 2554–2562.

De Smedt T, de Jong A, Van Leemput W, et al. Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment. Br J Sports Med 2007 41:816–19.

Ersek RA. Transcutaneous electrical neurostimulation: a new therapeutic modality for controlling pain. Clin. Orthop. Rel. Res. 1977. 12:314-24.

Gruchow HW, Pelletier D. An epidemiologic study of tennis elbow. Incidence, recurrence, and effectiveness of prevention strategies. Am J Sports Med 1979;7:234–8.

Kandemir U, Fu F, McMahon P. Elbow injuries. Curr Opin Rheumatol 2002;14:160–7.

Kulund D. Tennis injuries: prevention and treatment a review. Am J Sports Med 1979;7(4):


Mercola JM and Kirsch DL. The basis for microcurrent electrical therapy in conventional medical practice. J advan med, 1995 92: 83-152.

Peters T, Baker C. Lateral epicondylitis. Clin Sports Med 2001;20(3):549–63.

Searle RD, Bennet Mi, Johnson MI, et al. Transcutaneous Electrical Nerve Stimulation (TENS) for Cancer Bone Pain. J Pain Symptom Manage. 2009. 37(3):424-8. doi: 10.1016/j.jpainsymman

Sharma H and Patel N. Effectiveness of TENS versus Intermittent Cervical Traction in patients with cervical radiculopathy. Int J Physiother Res. 2014. 2(6):787-92. ISSN 2321-1822 DOI: 10.16965/ijpr.2014.693

Shiri, R. and Viikari-Juntura, E. Lateral and medial epicondylitis: role of occupational factors. Best Pract Res Clin Rheumatol, 2001; 25(1): 43-57.

Shiri R, Viikari-Juntura E, Varonen H, et al. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol 2006;164:1065–74.

Tarek A.A. Microcurrent Electrical Nerve Stimulation in Tennis Elbow. Bull. Fac. Ph. Th. Cairo Univ., 2001 Vol. 16, No. (2)